Pc. Stomper et al., CATHEPSIN-D AND DYNAMIC MAGNETIC-RESONANCE-IMAGING GADOLINIUM ENHANCEMENT IN MALIGNANT AND BENIGN BREAST-LESIONS, Clinical cancer research, 3(4), 1997, pp. 559-563
Our purpose was to determine whether the expression of cathepsin D, a
proteolytic enzyme implicated in basement membrane degradation, is ass
ociated with dynamic magnetic resonance imaging (MRI) enhancement of b
reast lesions, Forty-five patients with 48 breast lesions underwent ga
dolinium-enhanced spoiled gradient recalled echo MRI followed by excis
ional biopsy and cathepsin D staining and semiquantitative measurement
in the lesions, There was no significant difference in cathepsin D st
aining of 25 malignant and 23 benign breast lesions. A significant ass
ociation was seen between high cathepsin D staining and positive axill
ary lymph nodes in invasive carcinomas, Nine of nine (100%) node-posit
ive carcinomas had high cathepsin D, as compared to three of seven (43
%) node-negative carcinomas (P = 0.02). No significant associations we
re observed between cathepsin D staining and MRT enhancement amplitude
, rate, or washout, Cathepsin D has no effect upon MRI gadolinium enha
ncement of malignant and benign breast lesions but is associated with
positive axillary lymph nodes in invasive carcinomas.